Approaches for probing allosteric interactions at 7 transmembrane spanning receptors

Progress in Molecular Biology and Translational Science

Volumn 115, Issue , 2013, Pages 1-59

  Klein, Michael T ^a   Vinson, Paige N ^a   Niswender, Colleen M ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

7TMR; Allosteric drug discovery; Allosteric modulator; GPCR; HTS; Keywords

Indexed keywords

EID: 84873886491     PISSN: 18771173     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-394587-7.00001-4     Document Type: Chapter

References (158)

1. J.P. Overington, B. Al-Lazikani, and A.L. Hopkins How many drug targets are there? Nat Rev Drug Discov 5 2006 993 996
2. P.J. Conn, A. Christopoulos, and C.W. Lindsley Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders Nat Rev Drug Discov 8 2009 41 54
3. T.M. Bridges, and C.W. Lindsley G-protein-coupled receptors: from classical modes of modulation to allosteric mechanisms ACS Chem Biol 3 2008 530 541
4. A. Christopoulos, and T. Kenakin G protein-coupled receptor allosterism and complexing Pharmacol Rev 54 2002 323 374
5. K.L. Pierce, R.T. Premont, and R.J. Lefkowitz Seven-transmembrane receptors Nat Rev Mol Cell Biol 3 2002 639 650
6. R.J. Lefkowitz Seven transmembrane receptors: something old, something new Acta Physiol (Oxf) 190 2007 9 19
7. L.F. Kolakowski Jr. GCRDb: a G-protein-coupled receptor database Receptors Channels 2 1994 1 7
8. A.J. Harmar Family-B G-protein-coupled receptors Genome Biol 2 2001 REVIEWS3013
9. C.M. Niswender, and P.J. Conn Metabotropic glutamate receptors: physiology, pharmacology, and disease Annu Rev Pharmacol Toxicol 50 2010 295 322
10. T. Kenakin, and L.J. Miller Seven transmembrane receptors as shapeshifting proteins: the impact of allosteric modulation and functional selectivity on new drug discovery Pharmacol Rev 62 2010 265 304
11. B.J. Melancon, C.R. Hopkins, M.R. Wood, K.A. Emmitte, C.M. Niswender, and A. Christopoulos Allosteric modulation of seven transmembrane spanning receptors: theory, practice, and opportunities for central nervous system drug discovery J Med Chem 55 2012 1445 1464
12. H. Mohler, J.M. Fritschy, and U. Rudolph A new benzodiazepine pharmacology J Pharmacol Exp Ther 300 2002 2 8
13. K. Leach, P.M. Sexton, and A. Christopoulos Allosteric GPCR modulators: taking advantage of permissive receptor pharmacology Trends Pharmacol Sci 28 2007 382 389
14. K. Leach, R.E. Loiacono, C.C. Felder, D.L. McKinzie, A. Mogg, and D.B. Shaw Molecular mechanisms of action and in vivo validation of an M4 muscarinic acetylcholine receptor allosteric modulator with potential antipsychotic properties Neuropsychopharmacology 35 2010 855 869
15. C. Valant, C.C. Felder, P.M. Sexton, and A. Christopoulos Probe dependence in the allosteric modulation of a G protein-coupled receptor: implications for detection and validation of allosteric ligand effects Mol Pharmacol 81 2012 41 52
16. S. Suratman, K. Leach, P. Sexton, C. Felder, R. Loiacono, and A. Christopoulos Impact of species variability and 'probe-dependence' on the detection and in vivo validation of allosteric modulation at the M4 muscarinic acetylcholine receptor Br J Pharmacol 162 2011 1659 1670
17. C. Koole, D. Wootten, J. Simms, C. Valant, R. Sridhar, and O.L. Woodman Allosteric ligands of the glucagon-like peptide 1 receptor (GLP-1R) differentially modulate endogenous and exogenous peptide responses in a pathway-selective manner: implications for drug screening Mol Pharmacol 78 2010 456 465
18. D. Wootten, J. Simms, C. Koole, O.L. Woodman, R.J. Summers, and A. Christopoulos Modulation of the glucagon-like peptide-1 receptor signaling by naturally occurring and synthetic flavonoids J Pharmacol Exp Ther 336 2011 540 550
19. J.M. Mathiesen, A. Christopoulos, T. Ulven, J.F. Royer, M. Campillo, and A. Heinemann On the mechanism of interaction of potent surmountable and insurmountable antagonists with the prostaglandin D2 receptor CRTH2 Mol Pharmacol 69 2006 1441 1453
20. J.D. Urban, W.P. Clarke, M. von Zastrow, D.E. Nichols, B. Kobilka, and H. Weinstein Functional selectivity and classical concepts of quantitative pharmacology J Pharmacol Exp Ther 320 2007 1 13
21. G.J. Digby, P.J. Conn, and C.W. Lindsley Orthosteric- and allosteric-induced ligand-directed trafficking at GPCRs Curr Opin Drug Discov Dev 13 2010 587 594
22. J.D. Violin, and R.J. Lefkowitz Beta-Arrestin-biased ligands at seven-transmembrane receptors Trends Pharmacol Sci 28 2007 416 422
23. T.P. Kenakin Biased signalling and allosteric machines: new vistas and challenges for drug discovery Br J Pharmacol 165 2012 1659 1669
24. T. Kenakin A holistic view of GPCR signaling Nat Biotechnol 28 2010 928 929
25. J.W. Wisler, S.M. DeWire, E.J. Whalen, J.D. Violin, M.T. Drake, and S. Ahn A unique mechanism of beta-blocker action: carvedilol stimulates beta-Arrestin signaling Proc Natl Acad Sci USA 104 2007 16657 16662
26. J.E. Marlo, C.M. Niswender, E.L. Days, T.M. Bridges, Y. Xiang, and A.L. Rodriguez Discovery and characterization of novel allosteric potentiators of M1 muscarinic receptors reveals multiple modes of activity Mol Pharmacol 75 2009 577 588
27. T. Kenakin G protein coupled receptors as allosteric proteins and the role of allosteric modulators J Recept Signal Transduct Res 30 2010 313 321
28. C.M. Niswender, K.A. Johnson, N.R. Miller, J.E. Ayala, Q. Luo, and R. Williams Context-dependent pharmacology exhibited by negative allosteric modulators of metabotropic glutamate receptor 7 Mol Pharmacol 77 2010 459 468
29. M.J. Noetzel, J.M. Rook, P.N. Vinson, H.P. Cho, E. Days, and Y. Zhou Functional impact of allosteric agonist activity of selective positive allosteric modulators of metabotropic glutamate receptor subtype 5 in regulating central nervous system function Mol Pharmacol 81 2012 120 133
30. C.D. Weaver Triple-Addition assay protocols for detecting and characterizing modulators of seven-transmembrane receptors Current Protocols in Chemical Biology 3 2011 119 140
31. J.-H. Zhang, T.D.Y. Chung, and K.R. Oldenburg A simple statistical parameter for use in evaluation and validation of high throughput screening assays J Biomol Screen 4 1999 67 73
32. J.A. O'Brien, W. Lemaire, T.B. Chen, R.S. Chang, M.A. Jacobson, and S.N. Ha A family of highly selective allosteric modulators of the metabotropic glutamate receptor subtype 5 Mol Pharmacol 64 2003 731 740
33. S. Sharma, A.L. Rodriguez, P.J. Conn, and C.W. Lindsley Synthesis and SAR of a mGluR5 allosteric partial antagonist lead: unexpected modulation of pharmacology with slight structural modifications to a 5-(phenylethynyl) pyrimidine scaffold Bioorg Med Chem Lett 18 2008 4098 4101
34. A.L. Rodriguez, Y. Nong, N.K. Sekaran, D. Alagille, G.D. Tamagnan, and P.J. Conn A close structural analog of 2-methyl-6-(phenylethynyl)-pyridine acts as a neutral allosteric site ligand on metabotropic glutamate receptor subtype 5 and blocks the effects of multiple allosteric modulators Mol Pharmacol 68 2005 1793 1802
35. A.S. Hammond, A.L. Rodriguez, S.D. Townsend, C.M. Niswender, K.J. Gregory, and C.W. Lindsley Discovery of a novel chemical class of mGlu(5) allosteric ligands with distinct modes of pharmacology ACS Chem Neurosci 1 2010 702 716
36. P. Coward, S.D.H. Chan, H.G. Wada, G.M. Humphries, and B.R. Conklin Chimeric G proteins allow a high-throughput signaling assay of Gi-coupled receptors Anal Biochem 270 1999 242 248
37. E. Kostenis, M. Waelbroeck, and G. Milligan Techniques: promiscuous Gα proteins in basic research and drug discovery Trends Pharmacol Sci 26 2005 595 602
38. T. Yokoyama, N. Kato, and N. Yamada Development of a high-throughput bioassay to screen melatonin receptor agonists using human melatonin receptor expressing CHO cells Neurosci Lett 344 2003 45 48
39. S. Blattermann, L. Peters, P.A. Ottersbach, A. Bock, V. Konya, and C.D. Weaver A biased ligand for OXE-R uncouples Galpha and Gbetagamma signaling within a heterotrimer Nat Chem Biol 8 2012 631 638
40. C.D. Weaver, D. Harden, S.I. Dworetzky, B. Robertson, and R.J. Knox A thallium-sensitive, fluorescence-based assay for detecting and characterizing potassium channel modulators in mammalian cells J Biomol Screen 9 2004 671 677
41. G. Bhave, B.A. Chauder, W. Liu, E.S. Dawson, R. Kadakia, and T.T. Nguyen Development of a selective small-molecule inhibitor of Kir1.1, the renal outer medullary potassium channel Mol Pharmacol 79 2011 42 50
42. L.M. Lewis, G. Bhave, B.A. Chauder, S. Banerjee, K.A. Lornsen, and R. Redha High-throughput screening reveals a small-molecule inhibitor of the renal outer medullary potassium channel and Kir7.1 Mol Pharmacol 76 2009 1094 1103
43. C.M. Niswender, K.A. Johnson, Q. Luo, J.E. Ayala, C. Kim, and P.J. Conn A novel assay of Gi/o-linked G protein coupled receptor coupling to potassium channels provides new insights into the pharmacology of the group III metabotropic glutamate receptors Mol Pharmacol 73 2008 1213 1224
44. R.G. Gentles, K. Grant-Young, S. Hu, Y. Huang, M.A. Poss, and C. Andres Initial SAR studies on apamin-displacing 2-Aminothiazole blockers of calcium-Activated small conductance potassium channels Bioorg Med Chem Lett 18 2008 5316 5319
45. R.G. Gentles, S. Hu, Y. Huang, K. Grant-Young, M.A. Poss, and C. Andres Preliminary SAR studies on non-Apamin-displacing 4-(aminomethylaryl) pyrrazolopyrimidine K(Ca) channel blockers Bioorg Med Chem Lett 18 2008 5694 5697
46. X.P. Huang, T. Mangano, S. Hufeisen, V. Setola, and B.L. Roth Identification of human Ether-A-go-go related gene modulators by three screening platforms in an academic drug-discovery setting Assay Drug Dev Technol 8 2010 727 742
47. Q. Li, M. Rottlander, M. Xu, C.T. Christoffersen, K. Frederiksen, and M.W. Wang Identification of novel KCNQ4 openers by a high-throughput fluorescence-based thallium flux assay Anal Biochem 418 2011 66 72
48. W.A. Schmalhofer, A.M. Swensen, B.S. Thomas, J.P. Felix, R.J. Haedo, and K. Solly A pharmacologically validated, high-capacity, functional thallium flux assay for the human Ether-A-go-go related gene potassium channel Assay Drug Dev Technol 8 2010 714 726
49. S.A. Titus, D. Beacham, S.A. Shahane, N. Southall, M. Xia, and R. Huang A new homogeneous high-throughput screening assay for profiling compound activity on the human ether-A-go-go-related gene channel Anal Biochem 394 2009 30 38
50. A.P. Wojtovich, D.M. Williams, M.K. Karcz, C.M. Lopes, D.A. Gray, and K.W. Nehrke A novel mitochondrial K(ATP) channel assay Circ Res 106 2010 1190 1196
51. B. Zou, H. Yu, J.J. Babcock, P. Chanda, J.S. Bader, and O.B. McManus Profiling diverse compounds by flux- and electrophysiology-based primary screens for inhibition of human ether-A-go-go related gene potassium channels Assay Drug Dev Technol 8 2010 743 754
52. R. Emkey, and N.B. Rankl Screening G protein-coupled receptors: measurement of intracellular calcium using the fluorometric imaging plate reader Methods Mol Biol 565 2009 145 158
53. A.L. Rodriguez, M.D. Grier, C.K. Jones, E.J. Herman, A.S. Kane, and R.L. Smith Discovery of novel allosteric modulators of metabotropic glutamate receptor subtype 5 reveals chemical and functional diversity and in vivo activity in rat behavioral models of anxiolytic and antipsychotic activity Mol Pharmacol 78 2010 1105 1123
54. C.J. Langmead, V.A. Fry, I.T. Forbes, C.L. Branch, A. Christopoulos, and M.D. Wood Probing the molecular mechanism of interaction between 4-n-butyl-1-[4-(2-methylphenyl)-4-oxo-1-butyl]-piperidine (AC-42) and the muscarinic M(1) receptor: direct pharmacological evidence that AC-42 is an allosteric agonist Mol Pharmacol 69 2006 236 246
55. R. Rizzuto, and T. Pozzan Microdomains of intracellular Ca2 +: molecular determinants and functional consequences Physiol Rev 86 2006 369 408
56. J. Stables, A. Green, F. Marshall, N. Fraser, E. Knight, and M. Sautel A bioluminescent assay for agonist activity at potentially any G-protein-coupled receptor Anal Biochem 252 1997 115 126
57. E.L. Poul, S. Hisada, Y. Mizuguchi, V.J. Dupriez, E. Burgeon, and M. Detheux Adaptation of aequorin functional assay to high throughput screening J Biomol Screen 7 2002 57 65
58. M.A. Gilchrist, A. Cacace, and D.G. Harden Characterization of the 5-HT2b receptor in evaluation of aequorin detection of calcium mobilization for miniaturized GPCR high-throughput screening J Biomol Screen 13 2008 486 493
59. B. Jones, B. Holskin, S. Meyer, T. Ung, V. Dupriez, and S.Y. Flores Aequorin functional assay for characterization of G-protein-coupled receptors: implementation with cryopreserved transiently transfected cells Anal Biochem 400 2010 184 189
60. E. Silvano, M.J. Millan, C.M. la Cour, Y. Han, L. Duan, and S.A. Griffin The tetrahydroisoquinoline derivative SB269,652 is an allosteric antagonist at dopamine D3 and D2 receptors Mol Pharmacol 78 2010 925 934
61. M.F. Peters, K.S. Knappenberger, D. Wilkins, L.A. Sygowski, L.A. Lazor, and J. Liu Evaluation of cellular dielectric spectroscopy, a whole-cell, label-free technology for drug discovery on Gi-coupled GPCRs J Biomol Screen 12 2007 312 319
62. M.F. Peters, F. Vaillancourt, M. Heroux, M. Valiquette, and C.W. Scott Comparing label-free biosensors for pharmacological screening with cell-based functional assays Assay Drug Dev Technol 8 2010 219 227
63. R.P. McGuinness, J.M. Proctor, D.L. Gallant, C.J. van Staden, J.T. Ly, and F.L. Tang Enhanced selectivity screening of GPCR ligands using a label-free cell based assay technology Comb Chem High Throughput Screen 12 2009 812 823
64. E. Verdonk, K. Johnson, R. McGuinness, G. Leung, Y.W. Chen, and H.R. Tang Cellular dielectric spectroscopy: a label-free comprehensive platform for functional evaluation of endogenous receptors Assay Drug Dev Technol 4 2006 609 619
65. A.K. Shiau, M.E. Massari, and C.C. Ozbal Back to basics: label-free technologies for small molecule screening Comb Chem High Throughput Screen 11 2008 231 237
66. F. Coffman, R. Hamid, M.C. Cohen, R. Garippa, and S. Cohen Biophysical profiling of tumor cell lines Anal Cell Pathol (Amst) 34 2011 225 234
67. K. Dodgson, L. Gedge, D.C. Murray, and M. Coldwell A 100K well screen for a muscarinic receptor using the Epic label-free system - a reflection on the benefits of the label-free approach to screening seven-transmembrane receptors J Recept Signal Transduct Res 29 2009 163 172
68. G. Li, F. Lai, and Y. Fang Modulating cell-cell communication with a high-throughput label-free cell assay J Lab Autom 17 2012 6 15
69. J. Schmidt, K. Liebscher, N. Merten, M. Grundmann, M. Mielenz, and H. Sauerwein Conjugated linoleic acids mediate insulin release through islet G protein-coupled receptor FFA1/GPR40 J Biol Chem 286 2011 11890 11894
70. P.H. Lee, A. Gao, C. van Staden, J. Ly, J. Salon, and A. Xu Evaluation of dynamic mass redistribution technology for pharmacological studies of recombinant and endogenously expressed g protein-coupled receptors Drug Dev Technol 6 2008 83 94
71. Y. Fang, A. Ferrie, N. Fontaine, and P. Ki Yuen Optical biosensors for monitoring dynamic mass redistribution in living cells mediated by epidermal growth factor receptor activation Conf Proc IEEE Eng Med Biol Soc 1 2005 666 669
72. Y. Fang, and A.M. Ferrie Optical biosensor differentiates signaling of endogenous PAR1 and PAR2 in A431 cells BMC Cell Biol 8 2007 24
73. Y. Fang, and A.M. Ferrie Label-free optical biosensor for ligand-directed functional selectivity acting on beta(2) adrenoceptor in living cells FEBS Lett 582 2008 558 564
74. Y. Fang, A.M. Ferrie, N.H. Fontaine, J. Mauro, and J. Balakrishnan Resonant waveguide grating biosensor for living cell sensing Biophys J 91 2006 1925 1940
75. Y. Fang, A.M. Ferrie, and E. Tran Resonant waveguide grating biosensor for whole-cell GPCR assays Methods Mol Biol 552 2009 239 252
76. Y. Fang, G. Li, and A.M. Ferrie Non-invasive optical biosensor for assaying endogenous G protein-coupled receptors in adherent cells J Pharmacol Toxicol Methods 55 2007 314 322
77. F. Verrier, S. An, A.M. Ferrie, H. Sun, M. Kyoung, and H. Deng GPCRs regulate the assembly of a multienzyme complex for purine biosynthesis Nat Chem Biol 7 2011 909 915
78. H. Deng, H. Hu, M. He, J. Hu, W. Niu, and A.M. Ferrie Discovery of 2-(4-methylfuran-2(5H)-ylidene)malononitrile and thieno[3,2-b]thiophene-2- carboxylic acid derivatives as G protein-coupled receptor 35 (GPR35) agonists J Med Chem 54 2011 7385 7396
79. V. Goral, Y. Jin, H. Sun, A.M. Ferrie, Q. Wu, and Y. Fang Agonist-directed desensitization of the beta2-Adrenergic receptor PLoS One 6 2011 e19282
80. A.M. Ferrie, H. Sun, and Y. Fang Label-free integrative pharmacology on-target of drugs at the beta(2)-Adrenergic receptor Sci Rep 1 2011 33
81. A.M. Ferrie, Q. Wu, and Y. Fang Resonant waveguide grating imager for live cell sensing Appl Phys Lett 97 2010 223704
82. E.E. Codd, J.R. Mabus, B.S. Murray, S.P. Zhang, and C.M. Flores Dynamic mass redistribution as a means to measure and differentiate signaling via opioid and cannabinoid receptors Assay Drug Dev Technol 9 2011 362 372
83. M. Maj, V. Bruno, Z. Dragic, R. Yamamoto, G. Battaglia, and W. Inderbitzin (-)-PHCCC, a positive allosteric modulator of mGluR4: characterization, mechanism of action, and neuroprotection Neuropharmacology 45 2003 895 906
84. M.J. Marino, D.L. Williams Jr., J.A. O'Brien, O. Valenti, T.P. McDonald, and M.K. Clements Allosteric modulation of group III metabotropic glutamate receptor 4: a potential approach to Parkinson's disease treatment Proc Natl Acad Sci USA 100 2003 13668 13673
85. C.M. Niswender, K.A. Johnson, C.D. Weaver, C.K. Jones, Z. Xiang, and Q. Luo Discovery, characterization, and antiparkinsonian effect of novel positive allosteric modulators of metabotropic glutamate receptor 4 Mol Pharmacol 74 2008 1345 1358
86. R. Zhang, and X. Xie Tools for GPCR drug discovery Acta Pharmacol Sin 33 2012 372 384
87. U. Henriksen, J. Fog, F. Loechel, and M. Praestegaard Profiling of multiple signal pathway activities by multiplexing antibody and GFP-based translocation assays Comb Chem High Throughput Screen 11 2008 537 544
88. Y. Salomon, C. Londos, and M. Rodbell A highly sensitive adenylate cyclase assay Anal Biochem 58 1974 541 548
89. B.W. Agranoff, P. Murthy, and E.B. Seguin Thrombin-induced phosphodiesteratic cleavage of phosphatidylinositol bisphosphate in human platelets J Biol Chem 258 1983 2076 2078
90. L. Birnbaumer, S.L. Pohl, H. Michiel, M.J. Krans, and M. Rodbell The actions of hormones on the adenyl cyclase system Adv Biochem Psychopharmacol 3 1970 185 208
91. A.G. Gilman Guanine nucleotide-binding regulatory proteins and dual control of adenylate cyclase J Clin Invest 73 1984 1 4
92. P.H. McDonald, C.W. Chow, W.E. Miller, S.A. Laporte, M.E. Field, and F.T. Lin Beta-Arrestin 2: a receptor-regulated MAPK scaffold for the activation of JNK3 Science 290 2000 1574 1577
93. R.I. Osmond, M.F. Crouch, and V.J. Dupriez An emerging role for kinase screening in GPCR drug discovery Curr Opin Mol Ther 12 2010 305 315
94. T.D. Werry, A. Christopoulos, and P.M. Sexton Mechanisms of ERK1/2 regulation by seven-transmembrane-domain receptors Curr Pharm Des 12 2006 1683 1702
95. R.J. Lefkowitz, and S.K. Shenoy Transduction of receptor signals by beta-Arrestins Science 308 2005 512 517
96. R.J. Lefkowitz, J. Inglese, W.J. Koch, J. Pitcher, H. Attramadal, and M.G. Caron G-protein-coupled receptors: regulatory role of receptor kinases and arrestin proteins Cold Spring Harb Symp Quant Biol 57 1992 127 133
97. K.L. Pierce, and R.J. Lefkowitz Classical and new roles of beta-Arrestins in the regulation of G-protein-coupled receptors Nat Rev Neurosci 2 2001 727 733
98. A.G. Gilman A protein binding assay for adenosine 3′:5′- cyclic monophosphate Proc Natl Acad Sci USA 67 1970 305 312
99. C. Smith, N. Toohey, J.A. Knight, M.T. Klein, and M. Teitler Risperidone-induced inactivation and clozapine-induced reactivation of rat cortical astrocyte 5-hydroxytryptamine(7) receptors: evidence for in situ G protein-coupled receptor homodimer protomer cross-talk Mol Pharmacol 79 2011 318 325
100. G.J. Digby, M.J. Noetzel, M. Bubser, T.J. Utley, A.G. Walker, and N.E. Byun Novel allosteric agonists of M1 muscarinic acetylcholine receptors induce brain region-specific responses that correspond with behavioral effects in animal models J Neurosci 32 2012 8532 8544
101. M. Klein, and M. Teitler Distribution of 5-ht(1E) receptors in the mammalian brain and cerebral vasculature: an immunohistochemical and pharmacological study Br J Pharmacol 166 2012 1290 1302
102. W.F. Naccarato, R.E. Ray, and W.W. Wells Biosynthesis of myo-inositol in rat mammary gland. Isolation and properties of the enzymes Arch Biochem Biophys 164 1974 194 201
103. T.C. Turek-Etienne, E.C. Small, S.C. Soh, T.A. Xin, P.V. Gaitonde, and E.B. Barrabee Evaluation of fluorescent compound interference in 4 fluorescence polarization assays: 2 kinases, 1 protease, and 1 phosphatase J Biomol Screen 8 2003 176 184
104. I. Hemmilä, and S. Webb Time-resolved fluorometry: an overview of the labels and core technologies for drug screening applications Drug Discov Today 2 1997 373 381
105. B.E. Hawes, T. van Biesen, W.J. Koch, L.M. Luttrell, and R.J. Lefkowitz Distinct pathways of Gi- and Gq-mediated mitogen-Activated protein kinase activation J Biol Chem 270 1995 17148 17153
106. S. Fukuhara, M.J. Marinissen, M. Chiariello, and J.S. Gutkind Signaling from G protein-coupled receptors to ERK5/Big MAPK 1 involves Galpha q and Galpha 12/13 families of heterotrimeric G proteins. Evidence for the existence of a novel Ras AND Rho-independent pathway J Biol Chem 275 2000 21730 21736
107. R.M. Kramer, E.F. Roberts, P.A. Hyslop, B.G. Utterback, K.Y. Hui, and J.A. Jakubowski Differential activation of cytosolic phospholipase A2 (cPLA2) by thrombin and thrombin receptor agonist peptide in human platelets. Evidence for activation of cPLA2 independent of the mitogen-Activated protein kinases ERK1/2 J Biol Chem 270 1995 14816 14823
108. E.F. Ullman, H. Kirakossian, A.C. Switchenko, J. Ishkanian, M. Ericson, and C.A. Wartchow Luminescent oxygen channeling assay (LOCI): sensitive, broadly applicable homogeneous immunoassay method Clin Chem 42 1996 1518 1526
109. E.F. Ullman, H. Kirakossian, S. Singh, Z.P. Wu, B.R. Irvin, and J.S. Pease Luminescent oxygen channeling immunoassay: measurement of particle binding kinetics by chemiluminescence Proc Natl Acad Sci USA 91 1994 5426 5430
110. J. Peppard, F. Glickman, Y. He, S.I. Hu, J. Doughty, and R. Goldberg Development of a high-throughput screening assay for inhibitors of aggrecan cleavage using luminescent oxygen channeling (AlphaScreen) J Biomol Screen 8 2003 149 156
111. R.I. Osmond, A. Sheehan, R. Borowicz, E. Barnett, G. Harvey, and C. Turner GPCR screening via ERK 1/2: a novel platform for screening G protein-coupled receptors J Biomol Screen 10 2005 730 737
112. A. Sava, E. Formaggio, C. Carignani, F. Andreetta, E. Bettini, and C. Griffante NMDA-induced ERK signalling is mediated by NR2B subunit in rat cortical neurons and switches from positive to negative depending on stage of development Neuropharmacology 62 2012 925 932
113. U. Wilden, S.W. Hall, and H. Kuhn Phosphodiesterase activation by photoexcited rhodopsin is quenched when rhodopsin is phosphorylated and binds the intrinsic 48-kDa protein of rod outer segments Proc Natl Acad Sci USA 83 1986 1174 1178
114. J.L. Benovic, H. Kuhn, I. Weyand, J. Codina, M.G. Caron, and R.J. Lefkowitz Functional desensitization of the isolated beta-Adrenergic receptor by the beta-Adrenergic receptor kinase: potential role of an analog of the retinal protein arrestin (48-kDa protein) Proc Natl Acad Sci USA 84 1987 8879 8882
115. R.H. Oakley, C.C. Hudson, R.D. Cruickshank, D.M. Meyers, R.E. Payne Jr., and S.M. Rhem The cellular distribution of fluorescently labeled arrestins provides a robust, sensitive, and universal assay for screening G protein-coupled receptors Assay Drug Dev Technol 1 2002 21 30
116. Y. Namkung, C. Dipace, J.A. Javitch, and D.R. Sibley G protein-coupled receptor kinase-mediated phosphorylation regulates post-endocytic trafficking of the D2 dopamine receptor J Biol Chem 284 2009 15038 15051
117. V.V. Gurevich, R.M. Richardson, C.M. Kim, M.M. Hosey, and J.L. Benovic Binding of wild type and chimeric arrestins to the m2 muscarinic cholinergic receptor J Biol Chem 268 1993 16879 16882
118. B.J. Hanson, J. Wetter, M.R. Bercher, L. Kopp, M. Fuerstenau-Sharp, and K.L. Vedvik A homogeneous fluorescent live-cell assay for measuring 7-transmembrane receptor activity and agonist functional selectivity through beta-Arrestin recruitment J Biomol Screen 14 2009 798 810
119. J. Hess, P. Angel, and M. Schorpp-Kistner AP-1 subunits: quarrel and harmony among siblings J Cell Sci 117 2004 5965 5973
120. S. Butini, S. Gemma, G. Campiani, S. Franceschini, F. Trotta, and M. Borriello Discovery of a new class of potential multifunctional atypical antipsychotic agents targeting dopamine D3 and serotonin 5-HT1A and 5-HT2A receptors: design, synthesis, and effects on behavior J Med Chem 52 2009 151 169
121. J.Y. Altarejos, and M. Montminy CREB and the CRTC co-Activators: sensors for hormonal and metabolic signals Nat Rev Mol Cell Biol 12 2011 141 151
122. C.A. Saura, and J. Valero The role of CREB signaling in Alzheimer's disease and other cognitive disorders Rev Neurosci 22 2011 153 169
123. W.A. Carlezon Jr., R.S. Duman, and E.J. Nestler The many faces of CREB Trends Neurosci 28 2005 436 445
124. T.P. Kenakin Pharmacologic analysis of drug-receptor interaction 3rd ed. 1997 Lippincott-Raven Publishers Philadelphia
125. L.E. Limbird Cell surface receptors: a short course on theory & methods 3rd ed. 2005 Springer Science + Business Media New York
126. M. McKinney, and R. Raddatz Practical aspects of radioligand binding Current Protocols in Pharmacol. 33 2006 1.3.1 1.3.42
127. T. Kenakin The classification of seven transmembrane receptors in recombinant expression systems Pharmacol Rev 48 1996 413 463
128. V. Bernat, M.R. Heinrich, P. Baumeister, A. Buschauer, and N. Tschammer Synthesis and application of the first radioligand targeting the allosteric binding pocket of chemokine receptor CXCR3 ChemMedChem 7 2012 1481 1489
129. N.D.P. Cosford, J. Roppe, L. Tehrani, E.J. Schweiger, T.J. Seiders, and A. Chaudary [H-3]-methoxymethyl-MTEP and [H-3]-methoxy-PEPy: potent and selective radioligands for the metabotropic glutamate subtype 5 (mGlu5) receptor Bioorg Med Chem Lett 13 2003 351 354
130. L.H. Heitman, J. Oosterom, K.M. Bonger, C.M. Timmers, P.H.G. Wiegerinck, and A.P. IJzerman [3H]Org 43553, the first low-molecular-weight agonistic and allosteric radioligand for the human luteinizing hormone receptor Mol Pharmacol 73 2008 518 524
131. N. Shin, K. Solomon, N. Zhou, K.H. Wang, V. Garlapati, and B. Thomas Identification and characterization of INCB9471, an allosteric noncompetitive small-molecule antagonist of C-C chemokine receptor 5 with potent inhibitory activity against monocyte migration and HIV-1 infection J Pharmacol Exp Ther 338 2011 228 239
132. C. Tränkle, E. Mies-Klomfass, M.H.B. Cid, U. Holzgrabe, and K. Mohr Identification of a [3H]ligand for the common allosteric site of muscarinic acetylcholine M2 receptors Mol Pharmacol 54 1998 139 145
133. P. Jeffrey Conn, A. Christopoulos, and C.W. Lindsley Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders Nat Rev Drug Discov 8 2009 41 54
134. J.Q. Wang, W. Tueckmantel, A. Zhu, D. Pellegrino, and A.L. Brownell Synthesis and preliminary biological evaluation of 3-[(18)F]fluoro-5-(2- pyridinylethynyl)benzonitrile as a PET radiotracer for imaging metabotropic glutamate receptor subtype 5 Synapse 61 2007 951 961
135. V. Avlani, L.T. May, P.M. Sexton, and A. Christopoulos Application of a kinetic model to the apparently complex behavior of negative and positive allosteric modulators of muscarinic acetylcholine receptors J Pharmacol Exp Ther 308 2004 1062 1072
136. K. Leach, P.M. Sexton, and A. Christopoulos Quantification of allosteric interactions at G protein-coupled receptors using radioligand binding assays Curr Protoc Pharmacol 2011 Chapter 1, Unit 1.22
137. P. de Kruijf, H.D. Lim, L. Roumen, V.A. Renjaän, J. Zhao, and M.L. Webb Identification of a novel allosteric binding site in the CXCR2 chemokine receptor Mol Pharmacol 80 2011 1108 1118
138. K.J. Gregory, E.N. Dong, J. Meiler, and P.J. Conn Allosteric modulation of metabotropic glutamate receptors: structural insights and therapeutic potential Neuropharmacology 60 2011 66 81
139. C. Valant, K.J. Gregory, N.E. Hall, P.J. Scammells, M.J. Lew, and P.M. Sexton A novel mechanism of G protein-coupled receptor functional selectivity. Muscarinic partial agonist McN-A-343 as a bitopic orthosteric/allosteric ligand J Biol Chem 283 2008 29312 29321
140. H. Zhong, K.B. Hansen, N.J. Boyle, K. Han, G. Muske, and X. Huang An allosteric binding site at the human serotonin transporter mediates the inhibition of escitalopram by R-citalopram: kinetic binding studies with the ALI/VFL-SI/TT mutant Neurosci Lett 462 2009 207 212
141. K. Leach, J. Simms, P.M. Sexton, and A. Christopoulos Structure-function studies of muscarinic acetylcholine receptors Handb Exp Pharmacol 208 2012 29 48
142. K.J. Gregory, N.E. Hall, A.B. Tobin, P.M. Sexton, and A. Christopoulos Identification of orthosteric and allosteric site mutations in M2 muscarinic acetylcholine receptors that contribute to ligand-selective signaling bias J Biol Chem 285 2010 7459 7474
143. C. Koole, D. Wootten, J. Simms, E.E. Savage, L.J. Miller, and A. Christopoulos Second extracellular loop of human glucagon-like peptide-1 receptor (GLP-1R) differentially regulates orthosteric but not allosteric agonist binding and function J Biol Chem 287 2012 3659 3673
144. K.J. Gregory, P.M. Sexton, and A. Christopoulos Overview of receptor allosterism Curr Protoc Pharmacol 2010 Chapter 1, Unit 1.21
145. C.J. Langmead Determining allosteric modulator mechanism of action: integration of radioligand binding and functional assay data Methods Mol Biol 746 2011 195 209
146. V. Nawaratne, K. Leach, C.C. Felder, P.M. Sexton, and A. Christopoulos Structural determinants of allosteric agonism and modulation at the M4 muscarinic acetylcholine receptor: identification of ligand-specific and global activation mechanisms J Biol Chem 285 2010 19012 19021
147. A. Christopoulos, A. Lanzafame, A. Ziegler, and F. Mitchelson Kinetic studies of co-operativity at atrial muscarinic M2 receptors with an "infinite dilution" procedure Biochem Pharmacol 53 1997 795 800
148. L.T. May, L.J. Bridge, L.A. Stoddart, S.J. Briddon, and S.J. Hill Allosteric interactions across native adenosine-A3 receptor homodimers: quantification using single-cell ligand-binding kinetics FASEB J 25 2011 3465 3476
149. I. Gomes, A.P. IJzerman, K. Ye, E.L. Maillet, and L.A. Devi G protein-coupled receptor heteromerization: a role in allosteric modulation of ligand binding Mol Pharmacol 79 2011 1044 1052
150. S.M. Sephton, P. Dennler, D.S. Leutwiler, L. Mu, R. Schibli, and S.D. Kramer Development of [(18)F]-PSS223 as a PET tracer for imaging of metabotropic glutamate receptor subtype 5 (mGluR5) Chimia (Aarau) 66 2012 201 204
151. C.A. Wanger-Baumann, L. Mu, M. Honer, S. Belli, M.F. Alf, and P.A. Schubiger In vitro and in vivo evaluation of [18F]-FDEGPECO as a PET tracer for imaging the metabotropic glutamate receptor subtype 5 (mGluR5) Neuroimage 56 2011 984 991
152. C.A. Baumann, L. Mu, N. Wertli, S.D. Kramer, M. Honer, and P.A. Schubiger Syntheses and pharmacological characterization of novel thiazole derivatives as potential mGluR5 PET ligands Bioorg Med Chem 18 2010 6044 6054
153. C.A. Baumann, L. Mu, S. Johannsen, M. Honer, P.A. Schubiger, and S.M. Ametamey Structure-Activity relationships of fluorinated (E)-3-((6- methylpyridin-2-yl)ethynyl)cyclohex-2-enone-O-methyloxime (ABP688) derivatives and the discovery of a high affinity analogue as a potential candidate for imaging metabotropic glutamate recepors subtype 5 (mGluR5) with positron emission tomography (PET) J Med Chem 53 2010 4009 4017
154. S.M. Ametamey, V. Treyer, J. Streffer, M.T. Wyss, M. Schmidt, and M. Blagoev Human PET studies of metabotropic glutamate receptor subtype 5 with 11C-ABP688 J Nucl Med 48 2007 247 252
155. V. Treyer, J. Streffer, S.M. Ametamey, A. Bettio, P. Blauenstein, and M. Schmidt Radiation dosimetry and biodistribution of 11C-ABP688 measured in healthy volunteers Eur J Nucl Med Mol Imaging 35 2008 766 770
156. V. Treyer, J. Streffer, M.T. Wyss, A. Bettio, S.M. Ametamey, and U. Fischer Evaluation of the metabotropic glutamate receptor subtype 5 using PET and 11C-ABP688: assessment of methods J Nucl Med 48 2007 1207 1215
157. R.E. Nordquist, T. Steckler, J.G. Wettstein, C. Mackie, and W. Spooren Metabotropic glutamate receptor modulation, translational methods, and biomarkers: relationships with anxiety Psychopharmacology (Berl) 199 2008 389 402
158. E.D. Hostetler, W. Eng, A.D. Joshi, S. Sanabria-Bohorquez, H. Kawamoto, and S. Ito Synthesis, characterization, and monkey PET studies of [(1)(8)F]MK-1312, a PET tracer for quantification of mGluR1 receptor occupancy by MK-5435 Synapse 65 2011 125 135